GREBI is a novel androgen-regulated gene required for prostate cancer growth

Prostate

Volumn 66, Issue 8, 2006, Pages 886-894

  Rae, James M ^a   Johnson, Michael D ^b   Cordero, Kevin E ^a   Scheys, Joshua O ^a   Larios, José M ^a   Gottardis, Marco M ^c   Pienta, Kenneth J ^a   Lippman, Marc E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

Androgen receptor; Androgen induced growth; GREB1; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; BICALUTAMIDE; CYPROTERONE ACETATE; ESTRADIOL; ESTROGEN; FLUTAMIDE; LETROZOLE; METRIBOLONE; NILUTAMIDE; TESTOSTERONE; ANDROGEN; DNA; GREB1 PROTEIN, HUMAN; MESSENGER RNA; SMALL INTERFERING RNA; TUMOR PROTEIN;

ARTICLE; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN LNCAP; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DOSE RESPONSE; GENE; GENE EXPRESSION; GREB1 GENE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATE HYPERTROPHY; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA INTERFERENCE; CHEMISTRY; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; MALE; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTATE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANDROGENS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 33646728919     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20403     Document Type: Article

References (20)

1. American Cancer Society. Cancer Facts and Figures 2004. http://www.cancer.org/docroot/STT/stt_0.asp.
2. Lopez-Otin C, Diamandis EP. Breast and prostate cancer: An analysis of common epidemiological, genetic, and biochemical features. Endocr Rev 1998;19(4):365-396.
3. Jenster G. The role of the androgen receptor in the development and progression of prostate cancer. Semin Oncol 1999;26(4):407-421.
4. Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001;1(1):34-45.
5. Bubendorf L, Kononen J, Koivisto P, Schraml P, Moch H, Gasser TC, et al. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res 1999;59(4):803-806.
6. Linja MJ, Savinainen KJ, Saramaki OR, Tammela TL, Vessella RL, Visakorpi T. Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res 2001;61(9):3550-3555.
7. Rae JM, Johnson MD, Scheys JO, Cordero KE, Laios JM, Lippman ME. GREB1 is a critical regulator of hormone dependent breast cancer growth. Breast Cancer Res Treat 2005;92(2):141-149.
8. Rae JM, Lippman ME. Evaluation of novel epidermal growth factor receptor tyrosine kinase inhibitors. Breast Cancer Res Treat 2004;83(2):99-107.
9. Shah RB, Mehra R, Chinnaiyan AM, Shen R, Ghosh D, Zhou M, et al. Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program. Cancer Res 2004;64(24):9209-9216.
10. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25(4):402-408.
11. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, et al. LNCaP model of human prostatic carcinoma. Cancer Res 1983;43(4):1809-1818.
12. Veldscholte J, Berrevoets CA, Brinkmann AO, Grootegoed JA, Mulder E. Anti-androgens and the mutated androgen receptor of LNCaP cells: Differential effects on binding affinity, heat-shock protein interaction, and transcription activation. Biochemistry 1992;31(8):2393-2399.
13. Lau KM, LaSpina M, Long J, Ho SM. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: Regulation by methylation and involvement in growth regulation. Cancer Res 2000;60(12):3175-3182.
14. Hall RE, Birrell SN, Tilley WD, Sutherland RL. MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression. Eur J Cancer 1994;30A(4):484-490.
15. Coffey DS. Similarities of prostate and breast cancer: Evolution, diet, and estrogens. Urology 2001;57(4 Suppl 1):31-38.
16. Nelson CC, Hendy SC, Shukin RJ, Cheng H, Bruchovsky N, Koop BF, et al. Determinants of DNA sequence specificity of the androgen, progesterone, and glucocorticoid receptors: Evidence for differential steroid receptor response elements. Mol Endocrinol 1999;13(12):2090-2107.
17. Stossi F, Barnett DH, Frasor J, Komm B, Lyttle CR, Katzenellenbogen BS. Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: Distinct and common target genes for these receptors. Endocrinology 2004;145(7):3473-3486.
18. Jacobsen BM, Schittone SA, Richer JK, Horwitz KB. Progesterone independent effects of human progesterone receptors (PR) in estrogen receptor positive breast cancer: PR isoform-specific gene regulation and tumor biology. Mol Endocrinol 2005;19(3)574-587.
19. Nagase T, Ishikawa K, Miyajima N, Tanaka A, Kotani H, Nomura N, et al. Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA Res 1998;5(1):31-39.
20. Ghosh MG, Thompson DA, Weigel RJ. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res 2000;60(22):6367-6375.